Free Trial

Houlihan Lokey (HLI) Competitors

Houlihan Lokey logo
$180.71 -3.59 (-1.95%)
(As of 11:39 AM ET)

HLI vs. OWL, TPL, HOOD, TPG, BAM, CG, NMR, JEF, DOC, and LINE

Should you be buying Houlihan Lokey stock or one of its competitors? The main competitors of Houlihan Lokey include Blue Owl Capital (OWL), Texas Pacific Land (TPL), Robinhood Markets (HOOD), TPG (TPG), Brookfield Asset Management (BAM), The Carlyle Group (CG), Nomura (NMR), Jefferies Financial Group (JEF), Healthpeak Properties (DOC), and Lineage (LINE). These companies are all part of the "trading" industry.

Houlihan Lokey vs.

Blue Owl Capital (NYSE:OWL) and Houlihan Lokey (NYSE:HLI) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk.

In the previous week, Blue Owl Capital and Blue Owl Capital both had 10 articles in the media. Houlihan Lokey's average media sentiment score of 1.39 beat Blue Owl Capital's score of 0.71 indicating that Houlihan Lokey is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Blue Owl Capital
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Houlihan Lokey
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Blue Owl Capital has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Houlihan Lokey has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Blue Owl Capital pays an annual dividend of $0.72 per share and has a dividend yield of 3.1%. Houlihan Lokey pays an annual dividend of $2.28 per share and has a dividend yield of 1.2%. Blue Owl Capital pays out 423.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Houlihan Lokey pays out 46.6% of its earnings in the form of a dividend.

Houlihan Lokey has higher revenue and earnings than Blue Owl Capital. Houlihan Lokey is trading at a lower price-to-earnings ratio than Blue Owl Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Owl Capital$1.73B20.36$54.34M$0.17138.83
Houlihan Lokey$1.91B6.65$280.30M$4.8937.48

35.9% of Blue Owl Capital shares are held by institutional investors. Comparatively, 78.1% of Houlihan Lokey shares are held by institutional investors. 33.5% of Blue Owl Capital shares are held by insiders. Comparatively, 23.7% of Houlihan Lokey shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Houlihan Lokey received 242 more outperform votes than Blue Owl Capital when rated by MarketBeat users. However, 64.94% of users gave Blue Owl Capital an outperform vote while only 61.34% of users gave Houlihan Lokey an outperform vote.

CompanyUnderperformOutperform
Blue Owl CapitalOutperform Votes
50
64.94%
Underperform Votes
27
35.06%
Houlihan LokeyOutperform Votes
292
61.34%
Underperform Votes
184
38.66%

Blue Owl Capital currently has a consensus target price of $22.31, suggesting a potential downside of 5.46%. Houlihan Lokey has a consensus target price of $157.00, suggesting a potential downside of 14.35%. Given Blue Owl Capital's stronger consensus rating and higher possible upside, equities research analysts plainly believe Blue Owl Capital is more favorable than Houlihan Lokey.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Blue Owl Capital
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
Houlihan Lokey
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Houlihan Lokey has a net margin of 15.77% compared to Blue Owl Capital's net margin of 4.95%. Blue Owl Capital's return on equity of 19.98% beat Houlihan Lokey's return on equity.

Company Net Margins Return on Equity Return on Assets
Blue Owl Capital4.95% 19.98% 11.27%
Houlihan Lokey 15.77%19.29%11.61%

Summary

Blue Owl Capital beats Houlihan Lokey on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLI vs. The Competition

MetricHoulihan LokeyInvestment advice IndustryFinance SectorNYSE Exchange
Market Cap$12.74B$12.48B$10.52B$20.32B
Dividend Yield1.24%23.82%10.44%3.47%
P/E Ratio37.4829.2243.1235.77
Price / Sales6.655.293,432.6018.58
Price / Cash37.5719.8730.5718.55
Price / Book6.904.682.955.64
Net Income$280.30M$292.85M$1.02B$980.43M
7 Day Performance-1.94%-0.18%1.16%1.61%
1 Month Performance-1.31%1.30%3.31%3.62%
1 Year Performance60.89%31.00%22.56%24.83%

Houlihan Lokey Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLI
Houlihan Lokey
4.7747 of 5 stars
$180.71
-1.9%
$164.40
-9.0%
+61.9%$12.56B$1.91B36.962,260Analyst Downgrade
Positive News
OWL
Blue Owl Capital
2.7763 of 5 stars
$23.12
-2.6%
$22.31
-3.5%
+77.9%$34.53B$2.16B136.12540Positive News
TPL
Texas Pacific Land
1.7057 of 5 stars
$1,496.79
-6.4%
$694.17
-53.6%
+159.9%$34.40B$631.59M77.34100
HOOD
Robinhood Markets
4.02 of 5 stars
$37.77
+0.6%
$33.60
-11.0%
+255.2%$33.39B$2.41B65.192,200Analyst Upgrade
Insider Trade
TPG
TPG
2.9842 of 5 stars
$68.31
-2.4%
$58.83
-13.9%
+83.5%$24.93B$2.47B-202.091,850
BAM
Brookfield Asset Management
3.9273 of 5 stars
$57.22
+0.1%
$53.46
-6.6%
+60.3%$24.01B$4.06B50.582,400Positive News
CG
The Carlyle Group
4.3737 of 5 stars
$52.81
-0.8%
$53.33
+1.0%
+43.1%$18.89B$2.96B185.002,200Analyst Downgrade
Positive News
NMR
Nomura
4.1041 of 5 stars
$6.21
+2.1%
N/A+47.4%$18.45B$10.82B10.3126,850
JEF
Jefferies Financial Group
4.508 of 5 stars
$78.46
-0.9%
$71.33
-9.1%
+111.8%$16.12B$9.63B33.627,564Analyst Upgrade
Gap Up
DOC
Healthpeak Properties
4.3404 of 5 stars
$21.59
-1.8%
$22.86
+5.9%
+70.1%$15.10B$2.18B46.79200Positive News
LINE
Lineage
N/A$62.95
-0.7%
$90.75
+44.2%
N/A$14.38B$5.33B0.0026,127

Related Companies and Tools


This page (NYSE:HLI) was last updated on 12/9/2024 by MarketBeat.com Staff
From Our Partners